Source: https://www.jdsupra.com/authors/paul-devinsky/patent-litigation/
Timestamp: 2018-11-17 11:27:14
Document Index: 203946334

Matched Legal Cases: ['§ 271', '§ 1400', '§ 1400', '§ 284', '§ 284', '§ 112', '§ 112', '§ 112', '§ 271']

Paul Devinsky on Patent Litigation | JD Supra
Cert Alert: Cert Granted to Consider Whether Lost Profit Damages May Include Overseas Activities
The Supreme Court of the United States has agreed to consider whether US patent owners can recoup some profits lost because of infringement that occurs outside of the United States. WesternGeco LLC v. ION Geophysical Corp.,...more
2/2/2018 / Certiorari , Patent Infringement , Patent Litigation , Patent Ownership , Patents , SCOTUS
In a unanimous decision, the United States Supreme Court has clarified certain portions of the Biologics Price Competition and Innovation Act of 2009 (BPCIA), concluding (1) that biosimilar makers do not have to wait for...more
6/21/2017 / Biologics Price Competition and Innovation Act of 2009 , Biosimilars , BPCIA , FDA , Patent Litigation , Patents , Sandoz v Amgen , SCOTUS
On February 22, 2017, in reversing the decision of the US Court of Appeals for the Federal Circuit, an essentially unanimous US Supreme Court ruled that the “supply of a single component of a multi-component invention for...more
2/23/2017 / 35 U.S.C. § 271(e)(1) , Life Technologies Corp v Promega Corp , Patent Infringement , Patent Litigation , Patents
In a September 2015 panel decision, Achates Reference Publishing v. Apple, the US Court of Appeals for the Federal Circuit ruled that under 35 USC 314(b), decisions of the Patent Trial and Appeal Board (PTAB) finding that an...more
1/31/2017 / America Invents Act , Apple , Cuozzo Speed Technologies v Lee , Patent Litigation , Patent Trial and Appeal Board , USPTO
Supreme Court to Consider BPCIA Requirements for Biosimilars
The Supreme Court of the United States has granted certiorari in a case involving the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in the context of a biosimilars dispute. Sandoz, Inc. v. Amgen Inc. and...more
1/30/2017 / Amgen , Biosimilars , BPCIA , FDA , Patent Litigation , Sandoz , Sandoz v Amgen
No Place Like Home: Supreme Court to Review Whether § 1400(b) Alone Governs Venue
The Supreme Court of the United States has granted a petition for certiorari to consider whether 28 USC § 1400(b) is the sole and exclusive provision governing venue in patent infringement actions in light of amendments made...more
1/5/2017 / Patent Infringement , Patent Litigation , Patents , Petition for Writ of Certiorari
12/8/2016 / Apple , Apple v Samsung , Cell Phones , Design Patent , iPhone , Patent Infringement , Patent Litigation , Patents , Samsung , SCOTUS , Smartphones
10/12/2016 / Appeals , Apple , Apple v Samsung , En Banc Review , Obviousness , Patent Infringement , Patent Litigation , Patent Validity , Patents , Prior Art , Samsung , Smartphones , Substantial Evidence Standard
8/22/2016 / America Invents Act , Arbitration , Computer-Related Inventions , Covered Business Method Patents , Internal Investigations , International Arbitration , Korea , Patent Litigation , Patent Trial and Appeal Board , Patent-Eligible Subject Matter , Patents , USPTO , White Collar Crimes
Absent Contemporaneous Objection to Order for Single Trial on Subset of Claims, No Due Process Violation - Nuance Communications...
The US Court of Appeals for the Federal Circuit ruled that a patent owner’s due process rights were not violated when a district court found that the defendant did not infringe all of the originally asserted patents, even...more
4/6/2016 / Due Process , Patent Infringement , Patent Litigation
2/19/2016 / First Sale Doctrine , Foreign Sales , Kirtsaeng v. John Wiley & Sons , Lexmark , Patent Exhaustion , Patent Infringement , Patent Litigation , Quanta , SCOTUS , The Copyright Act
2/15/2016 / Attorney's Fees , Broadest Reasonable Interpretation Standard , Certiorari , Claim Construction , Copyright Infringement , Cuozzo Speed Technologies v Lee , First Sale Doctrine , Inter Partes Review (IPR) Proceeding , Judicial Review , Kirtsaeng v. John Wiley & Sons , Patent Litigation , Patent Trial and Appeal Board , SCOTUS
12/8/2015 / Claim Construction , Honda , Indefiniteness , Inter Partes Review (IPR) Proceeding , Patent Litigation , Patent Trial and Appeal Board , Prior Art
Supreme Court to Review Federal Circuit Standard for Treble Damage Awards Under § 284 - Halo Electronics, Inc. v. Pulse...
Taking its first IP cases of the current session, the Supreme Court has granted certiorari in two § 284 enhanced fee award patent cases: Halo Electronics, Inc. v. Pulse Electronics, Inc., S.Ct. No. 14-1513 (Oct. 19, 2015) and...more
11/5/2015 / Attorney's Fees , Certiorari , Damages , Enhanced Penalties , Halo v Pulse , Octane Fitness v. ICON , Patent Infringement , Patent Litigation , Patents , SCOTUS , Stryker Ortho , Treble Damages , Willful Infringement
PTAB Continues to Evolve Its Covered Business Method Patent Jurisprudence - International Internet Technologies, LLC and Red Rock...
10/7/2015 / Abstract Ideas , America Invents Act , CLS Bank v Alice Corp , Covered Business Method Proceedings , Patent Expiration , Patent Infringement , Patent Litigation , Patent Trial and Appeal Board , Patent-Eligible Subject Matter , Patents , Versata
In a trio of orders addressing the extent of express explanation required in a petition for post-grant review, the Patent Trial and Appeal Board (PTAB or Board) found each petition defective for lack of explanation regarding...more
9/9/2015 / Apple , Inter Partes Review (IPR) Proceeding , Patent Infringement , Patent Invalidity , Patent Litigation , Patent Trial and Appeal Board , Patents , Post-Grant Review , Prior Art
Expert Testimony Not Always a Guarantee for Appellate Review with Deference - Shire Development v. Watson Pharmaceuticals; Teva...
Addressing the impact of expert testimony used during claim construction, the U.S. Court of Appeals for the Federal Circuit in a case remanded by the U.S. Supreme Court, following its January 5, 2015 decision in Teva...more
7/30/2015 / Appeals , Claim Construction , Clear Error Standard , Expert Testimony , Patent Litigation , Patents , Pharmaceutical Patents , Shire Development v Watson , Standard of Review , Teva v Sandoz
7/3/2015 / Appeals , Apple , Apple v Samsung , Apportionment , Design Patent , Patent Infringement , Patent Litigation , Patents , Samsung , Trade Dress
What Was Old Is New Again for Means + Function Claim Elements
The U.S. Court of Appeals for the Federal Circuit, sitting en banc for the limited purpose of revisiting when claims invoke the means-plus-function language of 35 U.S.C. § 112, ¶ 6 (§ 112(6)) (now § 112(f)) replaced a part of...more
6/19/2015 / Intellectual Property Litigation , Means-Plus-Function , Patent Infringement , Patent Litigation , Patents , Software
The U.S. Supreme Court (Justice Kennedy writing for the majority) has now eliminated a defense that has been available to parties accused of actively inducing patent infringement under 35 USC § 271(b). The Court held that a...more
5/29/2015 / Cisco , Cisco v CommilUSA , Good Faith , Honest Belief Defense , Induced Infringement , Patent Infringement , Patent Invalidity , Patent Litigation , Patents , SCOTUS
The U.S. Court of Appeals for the Federal Circuit has sua sponte ordered an en banc hearing to consider the issue of international patent exhaustion. Lexmark International, Inc. v. Impression Products, Inc., Case No. 14-1617...more
5/15/2015 / Appeals , Lexmark , Patent Exhaustion , Patent Litigation , Patents
3/3/2015 / Appeals , Medical Devices , Patent Infringement , Patent Litigation , Patents
2/16/2015 / Infringement , Intellectual Property Litigation , Laches , Patent Infringement , Patent Litigation , Patents , Petrella v. MGM , Statute of Limitations
In a 7–2 decision penned by Justice Breyer, the Supreme Court of the United States overturned the de novo standard as the sole standard of review issues arising in claim construction. Teva Pharmaceuticals USA v. Sandoz,...more
2/4/2015 / Claim Construction , Clear Error Standard , De Novo Standard of Review , Federal Rules of Civil Procedure , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents , SCOTUS , Teva v Sandoz
1/23/2015 / Claim Construction , Clear Error Standard , De Novo Standard of Review , Federal Rules of Civil Procedure , Patent Litigation , Patents , Pharmaceutical Industry , Pharmaceutical Patents , SCOTUS , Teva v Sandoz